Price movement over the last 24 hours
Aegon Ltd. vs Illumina, Inc. — how do they compare? Aegon Ltd. trades at $8.73 (market cap $12.98B), while Illumina, Inc. trades at $189.08 (market cap $29.01B). The key difference: Illumina, Inc. is far larger — about 2.2× Aegon Ltd.'s market cap, and Aegon Ltd. pays a 5.3% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| AEG | ILMN | |
|---|---|---|
Market Cap | $12.98B | $29.01B |
Sector | Financials | Health |
52-Week High | $8.79 | $194.33 |
52-Week Low | $6.79 | $91.00 |
Enterprise Value | $14.11B | $30.40B |
Dividend Yield | 5.3% | — |
Trailing returns across standard periods
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →